Lyophilized Vials
Source: Baxter Healthcare Corporation -- BioPharma Solutions
The process of freeze drying can achieve product stability, and improved shelf-life. BioPharma Solutions offers individual filling suites with lyophilization capacity, along with an intrinsically safe process that enables use of non-aqueous solvents.
Click Here To Download:
•White Paper: The Empirical Path To Cycle Development
The process of freeze drying can achieve product stability, and improved shelf-life. BioPharma Solutions offers individual filling suites with lyophilization capacity, along with an intrinsically safe process that enables use of non-aqueous solvents.
•White Paper: The Empirical Path To Cycle Development
•White Paper: The Empirical Path To Cycle Development
The process of freeze drying can achieve product stability, and improved shelf-life. BioPharma Solutions offers individual filling suites with lyophilization capacity, along with an intrinsically safe process that enables use of non-aqueous solvents.
Sizes and options:
- Sizes from 2 mL to 50 mL
- 13 mm and 20 mm sizes
- Inert, surface-coated, or standard stopper configurations
- Flip-off or tear-away seals
- Intrinsically safe lyophilizers
Traditional and Complex lyophilized vials:
- Cytotoxic
- Small molecules
- Biologics
BioPharma Solutions' team of scientists at our Lyophilization Center of Excellence can help optimize cycle times and offer innovative approaches for the development of formulations and freeze-drying cycles. Our scientists' proven expertise in bio and analytical services encompass multiple methods for thorough evaluation of biologics and small molecules.
Click Here To Download:•White Paper: The Empirical Path To Cycle Development
This website uses cookies to ensure you get the best experience on our website. Learn more